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ABSTRACT 
Introduction: Nanoparticles are small particles within nanoscale levels. Their size goes 
up to few hundred nanometers, although some sources state that nanoparticles are up to 
100nm in diameter. Structure and function can vary between different nanoparticle 
models, each depending on physical properties of particles as well as way of their 
production. Each particle represents one functional unit. One of the most used type of 
nanoparticle is mesoporous silica nanoparticle. This is round shaped nanoparticle made 
of mesoporous silica, which makes it widespread when it comes to the drug loading. 
Despite the thing that nanomedicine sounds perfect in theory and brings enormous 
potential into targeted drug delivery, in real life it is hard to predict its behavior in vitro, 
and especially in vivo.  
Objectives: One way to enhance synthesis of MSNs and improve its efficiency is use of 
microfluidic chips and techniques. Microfluidic chip brings opportunity to manipulate 
different fluid flow in order to synthesize nanoparticles inside a picoliter volume 
droplets. The first objective is to optimize the microfluidic system in order to create 
stable droplets in order to synthesize MSNs inside a droplet. Second objective was to 
wash out the sample and measure the particles in order to check their size. Third 
objective was to image the particles with TEM (Transmission Electron Microscope) to 
see if their shape and size are suitable for drug loading, coating and similar 
manipulations, as well as establishing the protocol for the full process.  
Methods: Optimization is conducted by adjusting different flow rates and concentration 
of CTAB, TEOS, SPAN65 which are surfactants, precipitates and solvents. The main 
goal of optimization is to create stable fluid flow and stable droplets. Optimization 
process is monitored in real time with high speed microscope camera. Fluid flows of 
each substance were adjusted with fluid flow pumps. The main goal is to create a stable 
flow thus having a stable droplets in a sample. After the formation and collection of  
stable droplets, the sample is centrifuged and washed with ammonium hydroxide and 
ethanol solution for three times. After washing sample should be taken to Zetasizer, in 
order to measure particle size. If the sample is within certain nanometer range, it will be 
stored and imaged with Transmission electron microscope. Obtained images will be 
prone to image analysis with imageJ, from which data analysis will be obtained as well. 
Keywords: Mesoporous Silica Nanoparticle (MSN), Transmission Electron Microscope 
(TEM), Cetyl Trimethyl Ammonium Bromide (CTAB), Tetra Orto Silicate (TEOS) 
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1. LITERATURE REVIEW  
3.2 Nanoparticles 
 
Nanoparticles are the core component of the nanotechnology field, which is rapidly 
emerging field, tightly correlated with drug delivery (Kumar et al., 2018). 
Nanoparticles represent particles that have size within certain nanoscale, usually 
between 1 and 100 nanometres in their diameter. They can form many shapes such as 
round, rod or prism shaped, and they are all unique for their properties (Vollath et al., 
2018). Since the size of the nanoparticles is up to 100nm, it is clear that they cannot be 
seen within certain light wavelengths, since their size is smaller than light wavelengths 
which usually ranges between 350-700nm and is known as visible light. This is the 
reason why it is needed to use electron microscopy in order to image or see 
nanoparticles (Khan et al., 2019). Even that nanoparticles are synthesized for their 
purpose, some of the nanoparticles can occur naturally. (Plane, 2012) 
As majority of nanoparticles is synthesized, that has been done in a way that they form 
certain shape, which also dictates its function, especially in the field of drug delivery 
and nanotechnology. They can form an excessive number of shapes, ranging from 
simple to more complex ones.  This shape can be simple as spherical or nonspherical 
shape such as rod, star shape, all the way up to forming chains of similar shaped 
nanoparticles (Guo et al., 2014). Properties of each nanoparticle dictate their function, 
and their behaviour. These properties encompass size of the particle, its shape, charge, 
thermal properties and density  (Khan et al., 2019). NPs can be divided in many groups 
according to their type or properties. Classification of nanoparticles can be different due 
to chemical properties, size, morphology and physical properties (Crucho and Barros, 
2017). According to their synthesis way and chemical properties they can be carbon 
based, silica nanoparticles, ceramic nanoparticles, metal core nanoparticles, 
semiconductor nanoparticles, as well as polymeric and lipid based (Guo et al., 2014). 
Different nanoparticles have different uses in scientific researches, pharmacy and also 
consumer industry.  
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3.3 Mesoporous Silica Nanoparticles 
 
Nanoparticles can be synthesized and developed from many materials and with different 
methods, but one kind of nanoparticles especially stands out when it comes to numerous 
studies, and it is mesoporous silica nanoparticles (Mohanraj and Chen, 2006). What 
makes MSNs to stand out is their unique properties which make them great potential for 
drug delivery. Some of these properties are their physical properties which include high 
surface area, unique structure, ease of modification of the physical properties and low 
toxicity. All of these properties are adjustable and prone to change, and that is what 
makes these nanoparticles special and suitable for drug delivery. All of these bring 
opportunity to increase drug absorption, drug loading and release  (Wang et al., 2015). 
The fact that is very specific for MSNs is that pore diameter can range between 2 and 50 
nanometres. This wide range within nanoscale brings many different opportunities for 
usage of these nanoparticles. The size of the whole particle can be changed and tuned 
with ease, which also affects the pore size and number of pores. One fact that makes 
MSNs unique is that they have two surfaces, inner and outer, which means doubling the 
function of the particles.  (Pednekar et al., 2017) 
Since one of the main uses of MSNs is drug delivery, it is very important to consider the 
effect of the nanoparticle itself to the body. This means if the particle is cytotoxic and 
biodegradable and if so, to what extent. When it comes to mesoporous silica 
nanoparticles, they have high biodegradability and low to none cytotoxicity, depending 
on their size. The hydrolytic degradability of these particles is almost 100%, but time of 
it may vary depending on a size of particle, as well as the surroundings of a particle, 
which is different for different organ or cell types   (Croissant et al., 2017) 
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Figure 1. Representation of degradation mechanism and regulating  dissolution factors 
of MSNs (Croissant et al., 2017) 
3.3.1 Synthesis of MSNs 
 
As mesoporous silica nanoparticles have vital role in drug delivery field due to their 
properties, it is crucial to be able to change these properties accordingly. This is done 
with the synthesis of the MSNs, and different settings and components used in synthesis 
dictate the properties of MSNs. Since they load specific drugs, it is crucial that drug 
affects just the targeted area, and this depends on the particle properties (Vallet-Regí et 
al., 2017).  There are different synthesis methods, but one can be considered most 
common and best established, and this method is known as sol-gel method. This method 
is consisted of creating silica carriers which synthesizes from tetraethyl orthosilicate 
known as TEOS, and cetyltrimethylammonium bromide (CTAB) as template and pore 
generator at the same time. Properties can be altered by changing the ratio of water and 
TEOS, as well as CTAB concentration. Since CTAB is surfactant, its amount highly 
affects surface area and the number of pores. Cetyltrimethylammonium bromide  is used 
as a template for silica precursors, and it is in form of micelles, so its concentration 
affects the number and size of surfactant micelles, which finally affects the size of 
particles and their porosity. (Vazquez et al., 2017) 
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Figure 2. Illustration of MSN production and its synthesis within the sol gel method 
(Pednekar et al., 2017) 
Particles produced with sol-gel method are measured and characterised by dynamic 
light scattering and zeta potential count. Synthesis properties affect the size and shape of 
the particle, as well as their morphology. Although sol-gel method is effective, it is time 
consuming, and not fully efficient, since all the particles are synthesized within bulk and 
moderate number of them is not synthesized properly and unusable (Vazquez et al., 
2017); (Alemán et al., 2007).  
Depending on a synthesis properties, different functions and tasks can be assigned to the 
MSNs, leading them to have extremely high loading capacity, as well as carry different 
drugs, which makes them superior to the orthodox drug delivery systems, due to their 
flexibility, versatility and reliability.  (Tang et al., 2012) 
3.3.2 CTAB 
 
Cetyl trimethylammonium bromide or CTAB is one of the main components needed in 
MSN synthesis. It is surfactant that forms micelles that behave as pattern for 
mesoporous silica nanoparticles (He et al., 2018). Despite the fact that it is vastly useful 
during the synthesis, CTAB is actually highly cytotoxic which is quite contrary to the 
purpose of nanoparticles. In order to get the full potential of MSNs, CTAB needs to be 
washed out, especially if nanoparticle is going to be applied in vivo (Wang et al., 2013). 
CTAB is very important in nanoparticle synthesis, because it is reactive with water, 
where it forms micelles. Its main purpose is forming the template and maintaining the 
shape of the particle until it completely synthesises. CTAB needs to be washed out of 
the sample due to its cytotoxicity, but excessive washing can also affect the product 
itself since a lot of product can be lost after CTAB is gone to maintain the desired 
shape. (Becker et al., 2010)  
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3.3.3 Application of MSNs 
 
Mesoporous silica nanoparticles present one of the major components in drug delivery 
field and pharmacokinetics, and they have found place in different fields such as drug 
delivery, protein delivery, cancer therapy, gene delivery and different responsive 
releases (Pednekar et al., 2017).  When it comes to the cancer therapy, main problem is 
that cancer drugs are usually instable, have poor solubility and very often don reach 
targeted cells as effective as they should. This is due to reactivity of the drug with its 
surroundings, which makes it less effective by the time it reaches targeted area. These 
problems can be compensated with loading the drug inside a stable mesoporous silica 
nanoparticle. By doing this, drug gets physical protection on the way to the cancer cells, 
which minimizes reaction and release of the drug before time, lowering drug 
degradation, thus increasing the concentration of the drug that reaches targeted area as 
well as drug uptake of cancer cells (Mellaerts et al., 2008)  
Similar to the cancer therapy concept, delivery of certain proteins can be used in 
therapeutic purposes. Protein as a molecule has a large weight and tertiary structure 
which makes it highly reactive. Protein molecules can be used in medical application as 
a targeted protein that reacts with targeted area (Senapati, 2018). As stated, protein is 
highly reactive, meaning it changes its structure and function quite easily, leading it to 
complete loss of its biological activity. This represents the biggest problem in drug 
delivery, which can be solved by loading protein to the MSN. By doing this, protein can 
easily be preserved and protected on its way to targeted area by porous structure that 
remains stable all the way up to targeted cells, thus increasing efficiency of the drug. 
(Sood and Panchagnula, 2001) 
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Figure 3. MSN characteristics and their effect on particle behaviour (Pednekar et al., 
2017) 
One of the promising but hard to execute methods in targeted drug delivery is using 
genes in therapeutic purposes. Therapeutic genes can be in form of plasmid  DNA, short 
RNA chains, and chain of just few nucleotides, all of them highly potent in repairing 
broken cell mechanisms and cancer therapy (Tang et al., 2012). Since charge of these 
molecules is negative, their half-life is also short due to their biological instability. Even 
they have high potential in targeted therapy, it is nearly impossible to transfer them to 
desired cell without them reacting with other cells on the way. One way to compensate 
this is using viral carrier, which is not considered safe as it can have undesired counter 
effects on healthy cells (Slowing et al., 2008).  This problem can be solved by 
modifying MSN pore size and loading genes into the nanoparticle. MSN behaves as 
nonviral carrier, and when combined with certain polymers can create positively 
charged surface, which creates strong bond with negative charged gene, minimising 
chances of gene interacting with other cells before it reaches targeted cell (Gao et al., 
2009); (Garg et al., 2011) .With smaller modification to the MSNs, such as increasing 
pore diameters in nanometres, it is possible to load whole plasmids into mesoporous 
silica nanoparticle, leaving the plasmid protected and maintaining its form all the way 
until interacting with targeted cell. (Li et al., 2011) 
The way of making MSNs fully potent in a way that they do not interact with any of the 
cells on the way then just the targeted cells, thus maximising drug absorption in the 
desired area, requires specific approach. This approach is called triggered release and it 
is stimulated by factors already presented in the organism, called internal stimulus, or 
external stimulus represented in predetermined pathway. Triggered release is a concept 
of major significance when it comes to targeted drug delivery, and it allows drug, genes 
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or proteins to be released to exact location, and in time and dosage controlled fashion. 
As far as external factors go, they can be used to enhance the drug delivery in manner of 
time, location and dosage of released drug. Most used external triggers are temperature, 
magnetic field, light, pH, temperature and use of enzymes. (Sun, 2012) 
In order for MSN to react with certain pH, modifications of particle need to be done, 
such as adding components that detach the cargo when in certain pH environment, for 
example acid environment around tumor cells (Nguyen et al., 2006). One of many 
examples is also adding shell on MSN which can open and close, depending on 
surrounding pH, meaning that it releases cargo from pores in desired environment, with 
corresponding pH value (Cauda et al., 2010) 
One of the simple but fascinating uses of MSNs is the drug release that is triggered by 
change in temperature. This is very useful in cancer therapy, since tumor cells have 
higher temperature than healthy cells. By this, it is possible to keep drug unreleased in 
normal circulation, thus delivering drug with full dose and full potential to cancer cells 
only (Fu et al., 2007). For example, it is possible to modify MSN by adding thermo-
sensitive polymer that covers the pores of mesoporous silica nanoparticles, which 
changes its conformation in environment with higher temperature, thus leaving pores 
open and releasing the drug to targeted area.  (Pelton, 2000) 
Convenient and remote controlled drug delivery to desired site can be executed with 
light irradiation. Light is radiation, represented by electromagnetic wavelength (Sliney 
et al., 1976). By exposing targeted area to certain light wavelengths, it is possible to 
induce drug release and drug uptake to from MSNs to targeted cells. In order to get this 
effect, it is necessary to make slight modification to MSNs by adding linkers that have 
photochemical response. These linkers are built in nanoparticle surface and cover the 
pores, but after the stimulus by light, they change their structure and leave pores open, 
leading to release of the drug.  (Ferris et al., 2009) 
3.3.4 Biocompatibility 
 
The rapid evolution in development of nanoparticles in general, but especially 
mesoporous silica nanoparticles has moved them to one of the most potent solutions 
when it comes to targeted drug delivery and nanomedicine fields. Having so many 
potential modifications and variable properties make it theoretically solution for every 
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targeted drug delivery problem, but in practice, there are still many issues, and one of 
them is question of MSNs biocompatibility and cytotoxicity. (Chithrani et al., 2006) 
Regarding of cytotoxicity, it is considered low, or there is no remarkable cytotoxicity, 
depending on the dosage. Some of the smaller particles may affect some cells, such as 
human dendritic cells and their viability, as well as erythrocytes. Some in vitro 
experiments show that cytotoxicity is directly proportional to size and morphology of 
MSN. MSNs do have cytotoxicity properties which are highly dependant on their size, 
morphology and targeted area. Some research did show small amounts of cytotoxicity in 
some experiments, such as aforementioned to red blood cells and dendritic cells, but 
also in some researches that observed long term studies, MSNs would accumulate in 
liver for few months but showing zero signs of cytotoxicity. Most of  these results are 
taken in vitro, and cannot be observed as final as they require more investigation and 
research (Sun, 2012). It was established that cellular uptake does depend on the size of 
particle, as well as that distribution of nanoparticles follow different patterns for 
different size of particle in nanometres (He et al., 2011). There are two most important 
parameters to consider regarding biocompatibility and those are size and surface. Since 
MSNs are prone to many variations, and allow many properties to be modified, it does 
affect there cytotoxicity, which in general, can be considered low for all MSNs  (He et 
al., 2010). 
3.4 Microfluidics 
 
Microfluidics represents one of the most emerging areas correlated with 
pharmacokinetics and drug delivery, and it is combination of different fields such as 
physics, chemistry, biology and biomedicine. These systems also use constant use of 
optics and imaging devices, making unique fusion often referred to as optofluidics. (Wu 
et al., 2012) 
Microfluidics offer the new concept what is called lab on a chip, which means that it is 
possible to take the big experiments on a microscale. This idea of lab on a chip can be 
considered revolutionising, because it brings opportunity to use smaller volumes of 
reagents and chemicals used, conduct the experiments on smaller scale, making it less 
expensive and more affordable worldwide. Smaller scales bring shorter time of 
conducting the research which can be crucial especially in field of targeted drug 
delivery (Figeys and Pinto). What makes microfluidics so interesting and outstanding is 
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the physics behind microscale. Since everything is happening on much smaller scale, it 
is possible to use the law of the physics in a way that is unimaginable on a macroscale. 
This brings so many opportunities, and also less cost, which is quite important today 
(Beebe et al., 2014).  
Starting point of every microfluidic research is construction of microchip, a place where 
whole experiment will be done, in a microscale. There are commercially available 
microchips, but it is possible to build and design microchip for experiment, by 
understanding the physics on a microscale (Brody et al., 1996). In order to successfully 
design a chip, there are few effects that need to be considered beforehand in order to get 
most comprehensive idea of what lab on a chip should look like, and how it should 
behave. These effects are surface to volume ratio, tension, fluidic resistance, diffusion 
and laminar flow. These are all physic concepts that are crucial in order to use chip in 
fields of biology, biomedicine and drug delivery (Beebe et al., 2014).  
Laminar flow represents condition where fluid stream is not considered to be a random. 
Since channels in microchip are small sized, flow can be considered almost always 
laminar. When it comes to the laminar flow, in order to mix two or more fluid flows, 
diffusion is required. One of the features of laminar flow is the possibility to create 
flows that maintain form, which leads to creation of droplets inside solution, and it is 
possible to affect their size and properties. All of this is done by using diffusion 
between two laminar fluid flows (Glass et al., 2008). 
 
Figure 4. On the picture above, example of diffusion and fluid flows within the chip are 
shown. On the left side it is illustration of two different flows that will not mix except 
by diffusion, while on the right side it is shown how two different directions of the flow 
move a part of one flow through the channel. The example on a right side can be used in 
creating droplets (Beebe et al., 2014) 
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By using all of these physics concepts, it is possible to build a lab on a chip which will 
bring high impact to the field, by allowing manipulation of fluid flows on a microscale 
levels. (Papautsky and Bhagat, 2013) 
Microfluidic system brings high operation rates on the table, which gives it significance 
especially when it comes to bioparticle application in clinical diagnostics where time is 
of the essence (Di Carlo, 2009). Optical imaging is also tightly correlated to 
microfluidic systems. It is essential to visualisation of lab on chip, as well as providing 
constant monitoring which is of major significance when it comes to the microscale 
experiments. Combination of optical imaging and microfluidic devices provides low 
cost and portable solution (Wu et al., 2012).  
 
3.5 HLB or Hydrophilic-lipophilic balance 
 
Hydrophilic-Lipophilic Balance is a scale that represents the measure of hydrophilic and 
hydrophobic of certain solution or element, most commonly surfactant, more precisely 
non-ionic surfactants. The reason why is this balance shown in a scale form is to better 
visualise the difference and balance between properties. Since surfactants are used to 
stabilise the emulsion, it is hard to predict how exactly they will affect the emulsion 
without knowing their hydrophobicity/hydrophilicity properties. HLB scale ranges from 
values of 0 as a lowest one on HLB scale, to value of 18 as highest possible value of 
Hydrophilic-Lipophilic Balance  (Ohshima et al., 2016). HLB value represents 
parameter used to predict and asses the size of the core micelles, which also helps 
understand the charge of the bulk solution. Knowing this, it is easy to assume that 
surfactant can stabilize the emulsion and its charge, as well as affect particle charge in 
bulk solution, all depending on surfactants HLB value. (Gacek and Berg, 2015) 
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Figure 5. Sample of most common HLB scale as well as certain agents and surfactants 
with their values on the scale 
 HLB can be calculated by different simple math formulas, depending on a surfactant 
properties. It should be noted that HLB is affected by temperature, as well as presence 
of other agents that change pH value of the solution (Schott, 1995) One of the most 
recent and convenient ways to easily determine the HLB balance of surfactants by using 
inversion temperature deviation. This method is reliable and fast, which makes it perfect 
for double checking the HLB balance of surfactant of the interest. (Nollet et al., 2019) 
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2. HYPOTHESIS AND AIMS  
Nanoparticles are greatly explored and their synthesis is well established. Theoretically 
nanoparticles are one of the best things that happened to drug delivery research, because 
they can provide many different usages and solutions. They can be synthesized in few 
different ways, using already established protocols. These protocols are convenient 
and bring solid results. But as every method, it has its setbacks and can be majorly 
improved. Usual nanoparticle synthesis protocols require a lot of time, and bring 
synthesis in a bulk. This means that big number of nanoparticle is created within 
suspension, and may affect the final product. Having extremely big number of particles 
within small space brings issues such as them interacting, sticking together, thus making 
them useless. And with high number of nanoparticle within suspension, it is high chance 
of them interacting and not being suitable for final product. 
One way of improving these issues is introducing microfluidic systems in the mix. It 
takes similar principle as a bulk method, but with major improvements in the execution. 
By moving synthesis inside a microfluidic chip, it is possible to create a droplets that 
will behave as a microreactor, and with each droplet produced it is possible to produce 
nanoparticles within. That is exactly the aim of this research, introducing new method to 
synthesize nanoparticle, which in theory brings even more solutions and 
opportunities for both creating the nanoparticles, and using them, especially in field of 
drug delivery. By using microfluidics, it is possible to affect the speed and size of 
droplet creation, thus impacting synthesis of nanoparticle directly, by affecting their 
time to form, as well as size and physical properties. By creating a template for particle 
as well as all of its compound around it, all within microfluid chip, it is possible to 
create numerous droplets with nanoparticles inside. This would lead to easier creation of 
particles with different properties, as well as shortening the time for them to form by 
significant amount, and the biggest advantage would be their distribution within a 
droplet as a microreactor, instead of having millions of them inside one suspension.  
Success in creating nanoparticles this way would also open the opportunity to load 
particles immediately with a protein or a drug for example, and all of that during the 
process of their synthesis, which could prove to be vastly significant.  
Main aim of the research is to introduce a novel method, a new way of synthesizing 
nanoparticles more effectively,  both physical property and time-wise. Shortening the 
time of synthesis, as well as producing more effectively, would highly impact their drug 
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delivery usage, since it is possible to produce more for less time, and change their 
physical properties quickly. This kind of method would quickly find its place in the 
field of pharmacokinetics and drug delivery because it brings new solution that offers 
easier, shorter, more personalized and effective way to synthesize and 
produce nanoparticles.  
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3. MATERIALS AND METHODS 
3.1 Designing the microfluidic chip 
 
Microchip represents quite universal unit, but despite its core simplicity, chip design 
varies a lot for different microfluidic chips with different purpose. Designing the 
microfluidic chip is very initial and simple step, but also one of the most important 
steps. All microfluidic chips follow the same concept, with major differences in design 
correlated with their purpose. Chip is used to mix two or more phases on a microscale, 
and usually consists two phases, inner and outer phase. Simple concept, which gets 
more complicated with every single phase or solution introduced into mix. This usually 
brings new challenges in designing the chip, since more channels have to be introduced, 
and on a microscale level, this is easier said than done. Every chip is constructed from 
glass tubes with different diameters (usually represented in millimetres), which 
represent different channels, inner and outer channel respectively. Each channel will 
have a certain solution or mixture which will flow through a glass tube and eventually 
mix with another solution, or create droplets within outer phase. 
Design of a microchip starts on a drawing board, and it does include of setting a 
protocol for chip building, with more abstract and creative approach. Starting point of 
every chip design is a well established protocol for building the simple microchip with 
two phases, inner and outer phase.  Example of the one of simplest chip designs is 
shown on picture below. 
 
Figure 6. Most simple chip design with its purpose, usually used as a starting point in 
any more complex chip design 
15 
 
 Since glass tubes are the main component of every microfluidic chip, setting their 
proper placement and position is the main goal of chip design and drawing. Only with 
this approach it is possible to predict and visualise the behaviour of different solutions 
that flow through the chip, as well as possible creation of droplets, as well as their size. 
As aforementioned, Types of microchip may vary depending on its purpose. Some 
experiments have well established protocols, and chip design is quite straightforward, 
while other experiments require more innovative design and  bring novel and less 
familiar outcome to the experiment  or method itself. Since this particular project 
required more than two solutions into chip, it was needed to come up with new chip 
design as well as trying out different chip types. 
 
Figure  7.Example of simple drawing board, emphasising the possibilities and ideas 
introduced into creating every chip, as well as whole process of improving the chip 
design 
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As it can be seen from the different chip drawings, there is a lot of trial and error, until a 
certain chip design is selected to be constructed, and used. After a discussion with co-
workers, a small protocol is established for a final design, and chip construction can 
begin. In picture below, the illustration of the final chip design is shown.  
 
Figure 8. Illustration of final chip design, as well as its purpose and basic idea of its 
usage 
3.2 Construction of microfluidic chip 
 
Contrary to designing part, which is more abstract and theoretical, constructing the 
microchip is more related to handcrafting. According to blueprint, and set protocol, all 
the glass tubes need to be cut and put together in order to fit the purpose.  First, 
corresponding borosilicate glass tubes are selected. Inner tube is separated with a PN-30 
Magnetic Glass Microelectrode Horizontal Needle Puller by Narishige Japan. This is a 
device that uses heat source as well as magnetic puller in order to separate borosilicate 
glass tube in two parts with cone shaped endings, symmetrical for both separated sides. 
Cone shaped end of each glass tubes require a fine sand paper treatment in order to 
make a smooth edges and symmetrical opening, where mixing will happen and droplets 
will form. After this step outer tube is cut with diamond cutter and in places where 
syringe comes, as drawn in designing process. Inner tube is placed inside outer tube and 
syringe is put in appropriate place and fixed with mixture of epoxy and hardener. Two 
metal tubes are placed to fit in the ends of outer tube and fixed with the mixture of 
epoxy glue and hardener. Chip is left 24h in order for glue to fully dry and thus provide 
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optimum results when used. It is very important to cut the tubes in right places and clog 
them with glue, in order to prevent mixing of solutions before predetermined place. 
 This provides optimum results, and allows easier manipulation of what is happening 
inside chip. Syringe caps are used to deliver solutions or mixtures to outer channels, and 
they prove to be very convenient.  
 
Figure 9.Chip built for this particular experiment with two inner channels, and a closer 
look to their positioning, shot with light microscope 
For this particular chip, borosilacte tubes were used for both inner and outer channels. 
For inner one, the tube with 1.10mm inner diameter, and for outer one, the tube with 
1.56mm inner diameter were used. The difference between these two diameters will 
provide enough space inside chip for mixture of solutions, as well as for uninterrupted 
flow of the oil phase. The seemingly small difference between two tubes is vastly 
important when it comes to controlling the flows inside the chip, thus manipulating the 
flow speeds, leaving minimum space for possible problems that might occur. The whole 
chip is constructed in specialised area with PN-30 Magnetic Glass Microelectrode 
Horizontal Needle Puller, and includes all the tools needed, such as all the glass tubes, 
diamond cutters, sand paper, epoxy and hardener, syringes, pinchers and forceps. The 
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chip construction area is placed inside hood, so it prevents dust and external factors to 
get in.  
Whole constructing process is monitored with a light microscope which helps to see the 
edges of tubes, as well as their placement. A small “chip building lab” is shown in a 
picture with all the tools mentioned. 
 
Figure 10.Small workplace under the hood that represents space exclusively intended 
for chip construction containing all the tools necessary as well as magnetic puller and 
waste 
3.3 Solution preparation for microfluidic chip 
 
This novel method required few different solutions and components used. Its 
optimisation could be separated in two different parts, with different solutions needed 
for each optimisation protocol. First one was using a simple two phases, oil and water 
phases, in order to find optimal settings for droplet synthesis. Idea was to create a most 
stable water droplets inside the oil phase, and using those settings as a main guideline in 
creating actual nanoparticles inside a droplet, using more components. Water phase was 
coloured with a food dye (5ul of food color in a 5ml of miliQ water), while oil phase 
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represented mixture of span80 surfactant and mineral oil.  Oil solution was prepared in 
three different concentrations: 2% (100mg span80 in 5ml mineral oil),  4%(200mg 
span80 in 5ml mineral oil) and  6% (300mg span80 in 5ml mineral oil). In order to 
create stable droplet it was need to make many combinations of different oil phase 
concentrations as well as fluid flow speeds.   
As creating nanoparticles inside the droplet is the main goal of this experiment, it was 
necessary to use all the right components and solutions that are used in common 
methods when it comes to nanoparticle synthesis, especially the mesoporous silica 
nanoparticles. After using the simple oil and water phase, and setting up a protocol for 
droplet synthesis, it was time to introduce all the components used in MSN synthesis, 
and establish their concentrations in order to create stable droplets, and create a new 
protocol. Principle is similar to first optimisation step, but more complicated, since it 
uses more solutions and mixtures, thus giving more options to be adjusted, such as 
concentration, and of course, fluid flow speeds. This part uses also two different phases, 
water and oil phase, where water phase is a mixture of few different solutions, and its 
mixing is happening inside a chip.  For oil phase, Span65 was used, but since it had 
very low to none solubility in mineral oil, oleic acid was used. Concentrations used for 
Span65 phase, were same as for Span80 in first optimisation, meaning oil phase was 
prepared in three different concentrations: 2% (100mg span65 in 5ml oleic acid),  
4%(200mg span65 in 5ml oleic acid) and  6% (300mg span65 in 5ml oleic acid). 
Water phase required two channels inside the microchip, where two solutions would 
mix inside a chip, as shown in chip design illustration, and create a water phase which 
would, finally produce droplets inside the oil phase. There are two main components in 
water phase, TEOS (Tetraethilsilicate) and CTAB (Cetyl Trimethyl Ammonium 
Bromide). All of these components are commonly used in bulk methods of MSN 
synthesis. The basic idea behind using these two components as main ones is that inside 
a chip, CTAB creates a template in water. This template occurs under alkaline pH and it 
is in form of micelles. This solution would further mix with TEOS solution inside a 
chip. TEOS is very reactive to water, and it precipitates upon encountering water phase. 
Within the mixture, precipitated TEOS should deposit over the CTAB micelles. All of 
this should happen within water phase, which creates droplets inside a span65 phase, 
thus having many templates with TEOS precipitate around them, inside each droplet, 
where droplet has a role as a microreactor. In order to prove this theory in practice, it 
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was necessary to establish concentrations of both CTAB and TEOS, and other 
components that would make solutions of the main two components for the water phase. 
After many calculations, it has been decided to mix TEOS with ethylene glycol, as well 
as trying to use it just as a TEOS, as it is highly reactive with water, and to prevent 
precipitation from happening before it mixes with water phase. Furthermore, solutions 
prepared for optimisation were stock TEOS solution, and solution of 45ul of TEOS 
inside 833.33ul ethylene glycol. For a water phase, there were several options. There 
were two different concentrations of CTAB in a MiliQ water, including 15mg of CTAB 
in 5ml MiliQ, and 32,5mg of CTAB in 5ml MiiQ. One more solution was added to the 
mix, as a third option, and that was 32,5mg CTAB with 151,389ul of Ammonium 
hydroxide in 5ml MiliQ.  
It was necessary to set up different solutions and their concentrations, in order to get the 
optimal results during optimisation, and predict the mixing behaviour and droplet 
formation inside a chip. A variety in concentrations of each component introduces more 
options in the optimisation step, as well as more solutions in creating a final product.  
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Core chemicals used: CTAB as Hexadecytrilmethylammonium Bromide by Sigma 
Aldrich, Germany; Span65 for Synthesis by Sigma Aldrich, Germany; Tetramethyl 
ortosilicate by Sigma Aldrich, Germany, amongst which are other chemicals used to 
dilute the core components or bind with them, such as Oleic acid, Ammonium 
hydroxide, 99% ethanol, miliQ water with pH of 6.9 and Ethylene glycol. 
 
Figure 11. Main components used in optimisation protocol, with a main goal of 
mesporous silica nanoparticles synthesis  
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3.4 Optimization of microfluidic protocol 
 
Optimization is a most complex step, and most time consuming. It is a point where all 
of previous steps come together. Since it is a novel method, optimization and protocol 
writing requires most time, and it is based on trial and error methods, because it needs 
to be done from the grassroots. The reason behind optimisation complexity is a big 
number of variables and combination included.  In this step, all of the prepared 
solutions and concentrations are put into syringes attached to the syringe pump system 
that will inject solutions into the microchip. Injecting the solutions is done with PHD 
Ultra Advanced Programmable Syringe Pump by Harvard Apparatus. These fluid flow 
pumps offer very accurate manipulation of fluid flows within each channel inside 
microchip. All phases were stored inside BD Plastic Pak 5ml Syringes during this 
process. 
 
 
Figure 12. Harvard Apparatus PHD Ultra Syringe Pump 
These pump offer easy real time adjustment of each syringe fluid flows. This feature is 
crucial because it allows changing of the settings on the go, as well as pausing the 
process and restarting it if somethings goes wrong. Harvard Apparatus PHD Ultra 
Syringe Pumps have been proven as a good choice, because they introduce almost 
infinite number of variables, allowing to change fluid flow speeds for each pump, as 
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well as being compatible with different capacity syringes, such as Becton Dickinson 
Plastipak syringes ranging from 1ml to 20ml volume capacity. Pumps also allow 
different settings in a volume per time scale, which mean it is possible to set up a fluid 
flow speed for one syringe in microliters/hour and other in millilitres/minute, according 
to targeted purpose. This future is crucial in setting an optimisation protocol, and brings 
many different solutions and opportunities, as well as affecting the protocol in real time, 
and changing it on the go. 
The optimization process was separated into two major phases. First one was writing 
optimization protocol for creating stable droplets, and it included simple two channel 
chip, as well as water phase with dye as a constant, and three different concentrations of 
oil phase. The goal of this first, less time consuming optimisation, was to get basic idea 
of which fluid flow speeds to use in order to create stable water phase droplets inside an 
oil phase. This was necessary in order to get basic idea on what fluid flow speeds to use 
in major goal of this experiment, which is creating nanoparticles inside these droplets. 
First optimisation was expected to bring major guidelines on how to set up whole 
system for three solutions, and within more complex microchip. The idea behind second 
optimisation step, one that took major time of whole experiment, was using knowledge 
from the water/oil phase optimisation and applying already familiar settings in order to 
mix TEOS and CTAB and creating those droplets inside span65 and oleic acid solution. 
All of the optimisation steps were monitored by high speed camera microscope at all 
times. This allowed monitoring of mixing, and droplet creation, in real time and all the 
time. Also, this microscope was useful in taking the images of droplets within the 
sample, which were used in the image analysis of droplets, in order to determine their 
physical properties. Microscope camera used in this experiment was High Speed Digital 
Microscope camera by Meros, Dolomite Microfluidics, United Kingdom. This camera 
is designed to suit the purpose of monitoring microfluidics and recording droplet 
production in microscale at high speeds, which makes it ideal for this type of 
experiment. 
3.4.1 Optimisation protocol for creating stable droplets 
 
For this step, the simple chip was used, same one as illustrated in the chip design 
section.  Since this step included only two phases, water and oil phase, simple chip was 
suitable to use in this optimisation step.  
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Figure 13. Simple chip with inner and outer channel used in first optimisation step, 
imaged under light microscope 
Three constant fluid flows for each were determined. For outer phase, 1ml/hr; 2ml/hr 
and 5ml/hr are used for every solution, 2%, 4% and 6% respectively, while for inner 
phase fluid flow speeds of 100ul/hr;200ul/hr and 500ul were used. All of the inner 
channel speeds were combined for each of three of outer channel speed, as well as every 
single oil combination. This resulted in a collection of 25 samples in total, and after 
imaging those samples it was possible to see which fluid flow settings do have optimum 
results for creating stable droplets. Although this was just an introduction for the next 
optimisation step, it is very important because it determines the starting point for the 
core optimisation of the whole experiment, which in a novel method, such as this one is 
vastly important. By completing this step, it was easier to predict and determine the 
most optimal settings for synthesising MSNs inside a droplet. 
3.4.2 Optimisation protocol for creating nanoparticles inside droplet 
 
Setting up second optimisation protocol, in order to create a stable droplets as in first 
part, but with numerous nanoparticle templates and precipitate around it, and all inside a 
single droplet, was the most important step of the whole experiment. Since it is a novel 
method, there were no previous guidelines on how to start optimisation, except the 
observed results from previous optimisation. The results from protocol on creating 
stable droplets introduced a helpful outline on how and where to start this optimisation 
protocol. In theory, it was quite simple to predict the mixing of solutions inside a chip, 
and behaviour of the created droplets, but in practice, it had proven to be whole 
different story. Due to many possible combinations, and possibility to adjust all the 
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settings, this step was proven to be most time consuming and most trial and error 
consisted step.  
Since this chip required three syringes with three different solutions, the whole setup 
required to be upgraded compared to the first optimisation. As far as technicality goes, 
three Harvard Apparatus PHD Ultra Syringe Pumps were needed to operate at the same 
time, each one carrying different syringe. All three pumps were connected to the chip, 
while whole process was monitored by high speed camera microscope. This microscope 
camera records the process in microscale in real time, and offers recording and image 
taking without interrupting the process. This feature was of vital importance when it 
comes to adjusting the protocol, because it allowed adjusting to be fluent, and didn’t 
require stopping or pausing the process.  
 
Figure 14. Setup used for optimisation and synthesis, consisted of different syringe 
pumps and high speed camera microscope 
Hardware settings for this protocol are clearly determined, and they include three 
syringe pumps: one with TEOS mixture, one with CTAB mixture, and one with span65 
oil phase. All three are syringes are connected to corresponding channel on the chip. 
Span65 is exclusively connected to the outer channel, as it represents the outer/oil 
phase. Initially TEOS was connected to the outer channel as well, while the CTAB was 
connected to the inner channel. This way CTAB and TEOS would ideally mix and then 
create a water phase which would form droplets by being pushed into second  inner 
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channel by oil phase.  During the optimisation, CTAB and TEOS were switched, 
meaning syringe containing TEOS was moved to the inner channel in order to minimise 
TEOS contact with any other compound before mixing with CTAB, due to high 
reactivity of TEOS. Basic premise of this experiment was to mix CTAB and TEOS 
solutions on the microscale, inside the chip, where inside this mixture CTAB creates 
micelles in water, and TEOS precipitates when in contact with water. Precipitate would 
stick around the CTAB template, creating desired shape from silicate, thus forming 
nanoparticles around the template. All of this would happen within the each droplet that 
is formed inside the chip by being pushed through inner channel by oil phase, and 
creation of droplet happens due to different HLB factor and viscosity.  
In order to accomplish this, it was necessary to determine proper fluid flow speed for 
each solution respectively, thus creating a clear protocol containing most optimal 
settings in order to create stable droplets. This is done by combination of different 
solution concentrations and different flow speeds for each solution, which creates an 
excessive number of possible combinations. The process of optimising this step is 
explained further in text. 
 Figure  15. Illustration of the whole optimisation step, as well as the picture of forming 
the stable droplets caught in real time with high speed camera microscope 
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As fore- mentioned, optimisation was consisted over trial and error methods, as well as 
non-stop monitoring of the process. Starting step was using fluid flow speeds acquired 
from first optimisation step, as a guideline, and correcting these settings on the go in 
order to create a stable droplets. Fluid flow speeds for CTAB and TEOS were in a ul/hr, 
while speeds used for an oil phase, thus Span65 were used in a ml/hr. Significant 
increase in a speed between two phases was in order to assure that oil phase will push 
water phase mixture through inner channel and create a sustainable droplets.  Speed of 
each solution affects behaviour of fluids inside a chip, and can be adjusted individually 
for each solution. All of the parameters are adjusted one at the time, and formation of 
droplets is observed. As soon as droplet formation becomes constant over some time 
period, usually more than 10mins, sample is collected and will be prone to further 
analysis. By this method, numerous samples were collected, and all of settings used for 
each samples are stored in database. Each sample goes through certain time points, in 
which is observed if droplets merge or not, thus being able to see if droplets are stable 
or not. If they are preserved more than two hours, sample is taken for imaging and 
further analysis, because each droplet should contain thousands of MSNs, depending on 
a droplet size. 
3.5 Sample collection 
 
As for the first part of optimisation, after all of the combinations of fluid flow speeds 
and concentrations, 25 sample vials were collected. Each one of them was imaged with 
a microscope camera and droplets were imaged in order to see their physical properties. 
Every single sample was stored for a certain time period, and its droplet formation and 
stability was checked. All of the samples were checked in a two hour, four hour and 
twenty-four hour time scales. It was crucial to determine if droplets remained stable and 
maintained the initial structure 
For the second part, similar principle was followed. Since these samples contained more 
solutions and chemicals in the water phase, further work was required during the sample 
collection. Upon droplets being collected inside a 5ml glass vial, there was a lot of 
precipitate in each sample as well. Because of this, immediately upon collection, a small 
amount of sample was collected with pipette, and imaged with microscope camera, in 
order to check if there is only precipitate or droplets as well.   
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Figure 16. Sample of droplets containing CTAB/TEOS mixture inside a span65/oleic 
acid phase 
By using this practice it was possible to determine which samples are kept and observed 
through time points, and the ones containing only precipitate were discarded, as well as 
their settings from optimisation were written down as not suitable for droplet creation. 
All the samples will be imaged and analysed, and the ones containing stable droplets are 
prone to further imaging techniques and analyses.  
Sample collection is established protocol: collection of sample in 5ml glass vial for 
given settings, pipetting few microliters of sample and observing it under high speed 
camera microscope, repeating droplet formation monitoring through different time 
points, if droplets remain stable, samples go to further analysis for which there is 
another established protocol.  
3.6 Sample washing and preparing MSNs for imaging 
This step is exclusively reserved for the second part of optimisation and samples 
obtained during this process. Only samples that maintained droplet formation for more 
than two hours are prone to this protocol. Before the protocol, samples usually sit for 
four hours, this is estimation of time needed for TEOS to create a silicate shape around 
CTAB micelle templates. Ideally in each droplet by this time there should be formed 
thousands of CTAB micelles under the alkaline pH of miliQ water, and TEOS, also by 
encountering miliQ water, precipitates in silica form around the templates. This would 
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mean that every single droplet has a role of microreactor, in which there are numerous 
MSNs created, but still holding a CTAB template. Knowing this, it is clear that in order 
to get the nanoparticles, it is necessary to get rid of the surfactant template. Ironically, in 
order for washing to be done, droplets created need to be broken apart. It was crucial to 
have stable droplets for few hours in order to give enough time for precipitate to form, 
as well as to create a shape around the surfactant template. Main goal of this protocol is 
to break droplets to acquire the product stored within, as well as washing the product 
from all of the solutions and chemicals that occurred during the synthesis. By doing 
this, product is left pure and ready to be analysed and imaged, in order to check the 
success of the all previous steps. This protocol is established and follows up through 
two phases, preparing the sample and analysing the sample. For sample preparation, it is 
necessary to remove oil phase with Single Channel Manual Pipette by Rainin, US. 
Pipette models used are Pipet-Lite XLS Pipettes with different volume range, depending 
on amount of oil phase that needs to be extracted. For removing oil phase were 10-
100ul and 1-10ml volume Pipet-Lite XLS pipettes were used. After the maximum 
possible amount of oil is extracted from the vial, the droplets and precipitate are left in 
the sample, and it needs to be washed. Washing is done with the mixture of 20% 
ammonium hydroxide solution in ethanol. This solution is prepared by taking 5,7ml of 
stock ammonium hydroxide solution and mixing it with 4,3ml of 99,5% ethanol in order 
to get 10ml of 20% ammonium hydroxide solution. In order to wash the sample, 1ml of 
this solution is needed before vortexing and centrifuging the sample. High concentration 
of ammonia will react with surfactant template, CTAB in this case, and help wash it out 
so only silica particles are left. Washing is consisted of adding 1ml of ammonia solution 
to the sample, which is vortexed, and then put in centrifuge for seven minutes. This step 
n repeated three times, where after each centrifuge cycle, supernatant is removed, and 
new 1ml of ammonia solution is added. After this, sample will be taken for DLS 
analysis. 
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 Figure 17. On the left picture there is DLS reader and vortexer and centrifuge on the 
right 
 DLS stands for dynamic light scattering, and represents technique used to measure size 
of particles, as well as their potential, all by using properties of light scattering. DLS 
analyser in this experiment was Zetasizer by Malvern Panalytical, United Kingdom.   
Taking the certain amount from the sample in a vial and adding miliQ up to 1ml and 
analysing it with Zetasizer will provide necessary information on whether there are 
nanoparticles formed in the sample as expected, as well as their size and range. If the 
analysis shows there are nanoparticles synthesized, and they range between certain 
nanometer range, sample goes for further analysis, where actual MSNs synthesized in 
process will be imaged using the TEM (Transmission Electron Microscopy). 
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Figure 18. Detailed llustration of sample washing protocol as well as further analyses 
that sample is going through 
3.7 Transmission Electron Microscopy 
As this is the novel method, it requires constant monitoring and imaging. As fore-
mentioned, a droplet creation and produecd droplets are monitored and imaged  at all 
time by digital microscope, and light microscope is used for chip construction. as the 
main goal of the experiment is to create a nanoparticles, Mesoporous Silica 
Nanoparticles to be exact, a special imaging device will be necessary to check and 
image the sample since it is in a nanoscale. In order to do this, and obtain proper image 
that are able to show the nanoparticles, and their physical properties, it is necessary to 
use a Transmission Electron Microscope (TEM). TEM possesses bigger resolution than 
other microscopes used because it uses electron beam which penetrates through 
specimen in order to form an image. In this way, it is possible to image nanoparticles 
and more important, their detailed topography and properties, which is of major 
importance, since the physical properties of MSNs are crucial for its use.  
As stated in a previous protocol, sample that holds synthesised MSNs is prone to go 
through washing and DLS analysis steps before it is taken for TEM imaging. This will 
help to know if there is possibility of nanoparticles inside a sample, and is there a 
purpose for Transmission Electron Microscopy. After all the steps from sample washing 
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protocol, sample needs to be put on a metal grid. Possible nanoparticles are still in a 
suspension, which is put on a grid and dried, after which it is taken to imaging facility 
and will be imaged with TEM, and if images prove there are MSNs, images will be 
analysed in order to check the products physical properties.  
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3.8 Image Analysis protocol 
As mentioned before imaging of the droplets will be done with high speed microscope 
camera with magnification 1. For image analysis, software called ImageJ by Fiji will be 
used, as well as certain steps of image analysis within this software in order to get 
relevant and constant data for each sample. After trial and error methods, the image 
analysis protocol has been established and it was consisted of few steps in order to 
compensate for noise factors such as not even pixel values of background due to 
different lightning within images. The protocol was consisted of these steps, in exact 
order: Opening the image>convert image to 8-bit> duplicating image> Gaussian blur 
filter (radius:100) to duplicated image> image calculator: subtract original image from 
duplicated one> manual threshold> analyse particles (area size 300-Infinity(px); 
roundness:1)> show outlines. 
 
Figure 19. Screenshots from one of the analyses, with fore mentioned protocol steps, as 
an example 
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Particle size is measured as area in pixels. It is possible to have a scale in micrometres 
for example, and measure the scale in pixels, so that one unit of micrometre corresponds 
to few units of pixels, in order to interpret results easier and more familiar unit.  
When it comes to the imaging and image analysis of the second optimisation protocol, 
same imaging analysis protocol can be used, with some minor exceptions. Reason 
behind this lies in a greater amount of precipitate in each image of droplets taken during 
the second part of optimisation. This phenomenon vastly affects imaging and image 
analysis because it creates a lot of noise and artefacts that can affect the data that will be 
analysed. In order to cope with this problem, it was necessary to add minor tweaks to 
the aforementioned image analysis protocol, and this would be applied only for images 
where there is significant amount of precipitate that will affect image analysis. One 
method proved to be useful when it comes to coping with excessive amount of 
precipitate and that is applying the Laplacian filter during image analysis. Laplacian 
filter represents the 2 D measure or kernel, often applied to Gaussian filter, and it is 
used in order to improve edge detection. It is used with the Gaussian filter, where its use 
lies in the reducing sensitivity of Gaussian filter to noise. This proves as extremely 
useful method, because precipitate can be treated as noise, and as it mostly occurs very 
close to particles, it does affect the imaging and image analysis, in a way it may change 
a shape of particle during analysis, thus bring false results when it comes to extracting 
data. A seemingly small step, but of major significance when it comes to the image 
analysis of samples taken during the second part of optimisation. 
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4 RESULTS 
3.2 Creating stable water phase droplets inside an oil phase  
In this section images will be shown, and from different phases. Images from sample 
collection, images of droplets, as well as image analysis and table with average size of 
droplets, depending on production parameters. These table will represent quantitative 
results.
 Figure 20. 25 different  samples collected, each containing droplet produced with 
different settings 
 
Table 1. Table that shows fluid flow speed settings used for every sample for both oil, 
and water phase 
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Figure  20. Images of the all the samples taken from creating stable droplets protocol, 
taken with High speed Digital Microscope. Each image contains concentration and 
speed of two phases used to create shown droplets. Some samples were vortexed before 
imaging due to high concentration of droplets in certain samples. From images it is 
possible to see stable water phase droplets, their difference in size and properties 
correlated to different optimisation settings. After image analysis, it will be possible to 
determine the size of droplets for each sample, which can be used as guideline for 
further research and experiments, such as synthesizing nanoparticles inside a droplet. 
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Table 2. Each table above show the size of particles for each sample taken, presented in 
pixel areas. This is easy to convert to metric unit by assigning the measure line of 
1micrometer that corresponds to certain number of pixels. It is shown how the fluid 
flow speed affects the droplet size. 
As the tables and images above show, it was possible to create droplets using the 
optimisation protocol. After using different settings, droplets with different properties 
were created, and imaged with same technique. Image analysis allowed us to interpret 
these properties and their differences with numbers, and compare them. It is easy to 
observe how different settings affect size of the droplet. Trend of results showing 
droplet area in pixels can be observed through two different parameters, concentration 
of the oil phase, and fluid flow speed. From images it is clearly visible, that lower 
concentrations of the oil phase, 2% and 4% span80 in this case, are more suitable for 
droplet production than 6%. This means that 6% span80 oil phase is too thick and too 
viscous for water droplets, and makes imaging harder as well, because oil phase 
viscosity directly affects the brightness of the taken images. Regarding the fluid flow 
speeds and their variations, droplet size follows certain trend with different 
combinations of fluid flow speeds, with minor deviation in the results. These deviations 
are expressed in a way where particle is bigger or smaller than expected, which may be 
the consequence of imaging or image analysis as well. What can be concluded from 
analysed size of the droplets, it is clear that fluid flow speed and droplet size are 
inversely proportional, meaning the higher the fluid flow speed is, the lower droplet 
area is. This can be explained that higher speed creates higher force of the water phase 
span80 6% 1ml/hr span80 6% 2ml/hr span80 6% 5ml/hr
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exiting the capillary, thus creating more droplets at the time, meaning their area is 
smaller due to high speed production. 
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4.2 MSN synthesis using the microfluidic chip 
 
Table 3. Tables that show ratio of fluid speeds used in order to produce droplets with 
nanoparticles inside, as well as example of setting used in creating stable droplets 
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Figure 22. Images of ten samples collected using fluid flow speeds as stated in tables, 
shot by high speed digital microscope camera 
As it can be seen from comparison of images between two optimisations, it was quite 
challenging to produce stable droplets in a first place during the second part. Ten 
samples were collected, each one of them containing droplets and a lot of precipitate. 
Main problem was that droplets were not stable and would burst or merge within one of 
the time points. Only one sample had fully stable droplets, as well as not excessive 
amount of precipitate, and it was sample 11, as stated in a table or pictures labelled 
vial1. This sample was imaged within certain time points, and shown to have stable 
droplets, which means it was prone to the further analysis including dynamic light 
scattering and imaging. 
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4.3 Dynamic light scattering analysis 
 
Figure 23. In the tables above the result from DLS are shown, acquired by Zetasizer. In 
the first table it is visible that sample was measured three times, and the main 
parameters measured were number of particles, volume and intensity, all presented in 
diameter within a nanoscale. On bottom image, all of the setting used for dynamic light 
scattering are shown, such as dispersant, temperature, count rate, duration, position of 
measuring, as well as what cuvette u volume used. The graph shows size distribution by 
volume, where it is clearly visible that there were particles inside a sample, and their 
size ranged around 100nm. Zetasizer has calculated an average diameter in nanometres, 
which was 166,4nm for this sample.  
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Figure  24. Two graphs above show two different size distributions, by intensity, and 
by number, as well as diameter size of nanoparticles. intensity and number distribution 
are presented in percentage. Settings used are exact the same as in previous 
measurements shown. 
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Figure 25. In the figures above, cumulative results for size by intensity are shown, as 
well as detailed results table. In the first figure, All of the results are shown together in 
the one graph, showing the size of distributed particles in nanometre diameter, along 
size distribution by intensity shown in percentage. Settings are used as for the previous 
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measures, but shown as cumulant results in this figure, including polydispersiry of the 
particles.  
As for the results table, it shows very excessive table of measured sizes, shown as 
diameters in nanoscale (nanometres), and their volume percentage. This table proves 
very useful because it shows how much of the taken sample is consisted of the particles, 
and what is their size. This represents core information when it comes to the MSN 
synthesis, since usually these nanoparticles are within 100nm range. From this it can be 
seen if it was possible to synthesize nanoparticles with microfluidics, what is their size, 
as well as how much was produced within one sample. As this table shows, 
nanoparticles were created, and high percentage of them was within desired nanoscale. 
In our sample there were particles ranging from 78-122 nanometres in diameter, and 
particles with this size ranged from 2% to 9% of the volume percentage, depending on a 
size. It is also quite visible that a lot of particles were created within the sample, and 
with slightly bigger size than expected, ranging from 141-342 nanometres in diameter. 
Some of them were quite distributed within the sample, corresponding to around 9% of 
the volume percentage for various sized particles. A small percentage was consisted of 
very big particles with up to 531 nanometres in diameter. 
The measurements taken with Zetasizer using Dynamic light scattering were proved to 
be of  major significance. They have shown that is definitely possible to synthesize 
nanoparticle using microfluidic systems, and within desired nanorange, which is around 
100nm in diameter. It was also noticeable that quite decent amount of created 
nanoparticles are above the desired nanorange, making them less useful in drug 
delivery. This brings very promising results, but indicates that optimisation settings can 
be adjusted, in order to create and synthesize particles with more constant size and 
distribution, which would make an ideal product for drug loading, drug delivery and use 
in pharmacokinetics.  
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5 DISCUSSION 
 
Despite the fact that in general this is a novel method that has not been done in this 
manner before, it was consisted of few already established protocols. Designing and 
constructing the chip were mostly already established protocols, with some minor 
tweaks and adjustments needed, depending on a purpose of the chip. Establishing the 
protocol for microfluidic system, was not predetermined and was based on trial and 
error methods, and it had to be separated in two parts. First was just creating water 
phase droplets, while other part was synthesising Mesporous Silica Nanoparticles inside 
the droplet. This method of synthesising nanoparticles is a novel method, and did 
require a lot of work, adjustments and different approaches during the process. The 
reason behind this lies in numerous parameters that can be adjusted at the same time, 
and with introduction of more solutions, the number of possible combinations increases. 
That is the reason why the two optimisation steps were that complex, and consumed 
most of the time spent on this experiment. Both microfluidic optimisations were done 
from the outset, and were changed and redeveloped on the go, but they proved to be 
very promising in future work. Creating both stable droplets, and nanoparticles inside, 
was just and introduction for very important step, imaging. Imaging and image analysis 
were core steps of this experiment, because they allow converting the data to numbers, 
making the results of the experiment perceptible. Once the optimal flows were 
determined, samples were collected, and images were taken, assigning suitable image 
analysis protocol was needed. During the establishment, image analysis protocol also 
required trial and error, and different as well as more creative approaches to tackle the 
noise, uneven background and all the artefacts caused during imaging process. From 
this, it can be concluded that imaging can be done in a better way or method, using 
better settings than ones used in this experiment with High Speed Digital Camera 
Microscope. Although imaging was not perfect, it did provide images good enough that 
can be prone to image analysis, and all the problems faced during imaging were 
possible to overcome by creativity during image analysis. For example, uneven 
background lightning was compensated by duplicating image, adding Gaussian blur to 
the duplicated  image, then subtracting the two images thus creating third one with more 
even background lightning, meaning it is more suitable for particle analysis and 
lowering the possibility of background to interfere with analysis itself.  
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When it comes to creating stable water phase droplets inside an oil phase, protocol 
established proved to be quite successful. A lot of samples were collected using 
different settings, and all of them had quite stable droplets, as it is shown in the results 
section. From the images of these samples, it can be seen and concluded that lower 
concentration oil phase is more suitable for creating droplets. Higher concentration, 
such as 6% created more viscous solution, making it harder to image and analyse. From 
this optimisation step, after the imaging and analysis, it is concluded that 2% and 4% 
span80 solutions provide good oil phase which has good HLB  in order to create stable 
droplets. After analysis of each sample, it can be interpreted that physical properties of 
the droplet, such as size, are directly proportional to the fluid flow speeds used, and it 
does follow a certain trend. Few samples had bigger particle size than expected, but 
reason for this lies in imaging or image analysis.  From the graphs it is clearly visible 
that higher the water phase speed is, the lower the particle size.  This can be explained 
in a sense that higher speed creates higher force that water phase uses to exit the 
capillary, thus creating more particles at the time, as well as smaller in size. Results and 
methods from this step can be re-used in some other experiments that require creating 
water phase droplets inside an oil phase, but imaging technique can be improved.  
When it comes to synthesis of  MSNs inside a droplet, this experiment has brought a lot 
of negative results, with some results that look promising for future experiments. As this 
was a more complex, second optimisation part, and was representing the novel method, 
this outcome was expected. Nevertheless it did bring promising results, since not all the 
sample turn out to be what is considered a negative result.  One sample did give stable 
particles, and after following all the protocol steps, DLS managed to read that there are 
particles formed within desired range (in nanometres). This proves that this method can 
be used in order to synthesize MSN particles inside a single droplet. If this protocol gets 
finer tuning, it is possible to create a full product that will bring promising opportunities 
to the field of pharmacokinetics and drug delivery fields. Negative results also don’t 
necessarily bring bad news but provide good source of information as well. Negative 
results obtained during this experiment can be used as a guideline and starting point for 
similar experiment, or recreation of this one. The fact that it was within reach to 
synthesize nanoscale particles inside a microfluidic chip proves that hypothesis of this 
experiment was correct and it is possible and very imaginable to do it to full extent. 
Proof for this lies in data acquired from DLS, which clearly indicates particles within 
nanoscale synthesised inside a droplets that are within sample 
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The final step for the whole process, and a step that would be crucial for validating all 
the results obtained, is Transmission Electron Microscopy imaging, which would be 
able to image the nanoparticles, as well as their physical properties, such as shape, size 
and topography. Unfortunately, during this experiment, and prior to this crucial and 
final step, outbreak of the COVID-19 virus has taken its toll by shutting down the labs 
and imaging facilities, so it was impossible to finish this experiment and get final 
validation of the fact if the created particles were nanoparticles indeed or not. Since it 
was not possible to go through with TEM, results from DLS could not be confirmed 
with images, and it cannot be concluded with one hundred percent rate that the particles 
synthesized and analysed were mesoporous silica nanoparticles. Nevertheless, with all 
the aforementioned problems faced, which were expected since it is a novel method, it 
can be said that this new way of using microfluidic systems in order to produce MSNs 
is definitely possible, and it has great potential to find its place in a fields of drug 
delivery, drug loading and pharmacokinetics.  
What can be concluded is that the premise of this experiment stands on solid ground, 
but execution can be improved, especially in terms of imaging techniques. In order to 
finalise this experiment to its fully potential, it is necessary to improve mixing of the 
TEOS and CTAB within the microchip, and imaging as it is of core significance. Better 
imaging of droplets within the sample makes an easier image analysis, thus more solid 
results, and this can be done by using better microscope to image the sample after 
collecting, while High Speed Digital Camera Microscope should be kept as a 
monitoring tool.  
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